Discontinuation report AMINOSYN II
| Report ID | 20268 |
| Drug Identification Number | 00742619 |
| Brand name | AMINOSYN II 10% |
| Common or Proper name | Aminosyn II |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | HISTIDINE TRYPTOPHAN L-LYSINE L-ALANINE METHIONINE GLYCINE L-PROLINE L-ARGININE L-VALINE L-THREONINE L-ISOLEUCINE SERINE N-ACETYL-L-TYROSINE GLUTAMIC ACID L-ASPARTIC ACID L-PHENYLALANINE L-LEUCINE |
| Strength(s) | 300MG 200MG 1.05G 993MG 172MG 500MG 722MG 1.018G 500MG 400MG 1G 660MG 530MG 270MG 738MG 700MG 298MG 1G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1000ML & 2000ML |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-05-01 |
| Actual discontinuation date | 2017-05-01 |
| Remaining supply date | 2017-08-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-08-24 | French | Compare |
| v1 | 2017-08-24 | English | Compare |
Showing 1 to 2 of 2